Circulating miRNAs as a Predictive Biomarker of the Progression from Prediabetes to Diabetes: Outcomes of a 5-Year Prospective Observational Study.
biomarker
diabetes
miRNA
prediabetes
serum profiling
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
10 Jul 2020
10 Jul 2020
Historique:
received:
10
06
2020
revised:
01
07
2020
accepted:
07
07
2020
entrez:
16
7
2020
pubmed:
16
7
2020
medline:
16
7
2020
Statut:
epublish
Résumé
Due to a global increase in the prevalence of type 2 diabetes mellitus (T2DM), there is an urgent need for early identification of prediabetes, as these people have the highest risk of developing diabetes. Circulating miRNAs have shown potential as progression biomarkers in other diseases. This study aimed to conduct a baseline comparison of serum-circulating miRNAs in prediabetic individuals, with the distinction between those who later progressed to T2DM and those who did not. The expression levels of 798 miRNAs using NanoString technology were examined. Spearman correlation, receiver operating characteristic (ROC) curve analysis, and logistic regression modeling were performed. Gene ontology (GO) and canonical pathway analysis were used to explore the biological functions of the miRNA target genes. The study revealed that three miRNAs were upregulated in the serum samples of patients who later progressed to T2DM. Pathway analysis showed that the miRNA target genes were mainly significantly enriched in neuronal NO synthase (nNOS) signaling in neurons, amyloid processing, and hepatic cholestasis. ROC analysis demonstrated that miR-491-5p, miR-1307-3p, and miR-298 can be introduced as a diagnostic tool for the prediction of T2DM (area under the curve (AUC) = 94.0%, 88.0%, and 84.0%, respectively). Validation by real-time quantitative polymerase chain reaction (qRT-PCR) confirmed our findings. The results suggest that circulating miRNAs can potentially be used as predictive biomarkers of T2DM in prediabetic patients.
Identifiants
pubmed: 32664305
pii: jcm9072184
doi: 10.3390/jcm9072184
pmc: PMC7408684
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Biochim Biophys Acta. 2010 Jan;1802(1):2-10
pubmed: 19853658
Acta Diabetol. 2015 Jun;52(3):523-30
pubmed: 25408296
Acta Diabetol. 2014 Oct;51(5):823-31
pubmed: 24981880
World J Diabetes. 2015 Jun 25;6(6):850-67
pubmed: 26131326
Curr Genomics. 2010 Nov;11(7):537-61
pubmed: 21532838
Curr Hypertens Rep. 2018 Feb 26;20(2):12
pubmed: 29480368
Int J Mol Sci. 2019 May 07;20(9):
pubmed: 31067633
Future Virol. 2019 Feb;14(2):107-122
pubmed: 31406497
FEBS Lett. 2017 Jul;591(14):2091-2105
pubmed: 28626869
Nat Immunol. 2010 Oct;11(10):897-904
pubmed: 20835230
Int J Mol Sci. 2014 Jun 12;15(6):10567-77
pubmed: 24927146
Int J Obes (Lond). 2016 Jan;40(1):88-101
pubmed: 26311337
Mol Psychiatry. 2017 Sep;22(9):1327-1334
pubmed: 28044060
Cell Prolif. 2017 Feb;50(1):
pubmed: 27704627
Int J Oncol. 2015 Jul;47(1):43-50
pubmed: 25955829
Cell Death Dis. 2017 Mar 30;8(3):e2714
pubmed: 28358374
BMC Syst Biol. 2014;8 Suppl 4:S11
pubmed: 25521941
J Cancer. 2019 Jan 1;10(2):441-448
pubmed: 30719138
Oncol Rep. 2015 Aug;34(2):979-86
pubmed: 26034994
Diabetes Res Clin Pract. 2019 Jul;153:66-75
pubmed: 31152806
Pathol Res Pract. 2019 Nov;215(11):152643
pubmed: 31564569
BMC Bioinformatics. 2009 Feb 03;10:48
pubmed: 19192299
Ann N Y Acad Sci. 2011 Dec;1243:88-102
pubmed: 22211895
Int J Endocrinol. 2018 Mar 7;2018:6890501
pubmed: 29707000
J Cell Physiol. 2016 Jan;231(1):25-30
pubmed: 26031493
Diabetes. 2018 May;67(5):1013-1023
pubmed: 29453204
Aging (Albany NY). 2010 Mar 31;2(3):166-9
pubmed: 20375468
Clin Diabetes Endocrinol. 2019 May 9;5:5
pubmed: 31086677
Biomed Rep. 2019 Apr;10(4):250-258
pubmed: 30972221
PLoS One. 2015 Jun 05;10(6):e0128140
pubmed: 26046362
Mol Vis. 2009 Nov 09;15:2249-58
pubmed: 19936028
J Virol. 2018 Jul 31;92(16):
pubmed: 29899090
Diabetes. 2014 Jun;63(6):1850-4
pubmed: 24853901
J Neurosci. 2015 Jun 10;35(23):8701-17
pubmed: 26063905
FEBS Lett. 2015 Mar 24;589(7):812-21
pubmed: 25725194
Acta Pharmacol Sin. 2017 Sep;38(9):1205-1235
pubmed: 28713158
J Exp Med. 2017 Sep 4;214(9):2591-2610
pubmed: 28765400
Mol Neurodegener. 2014 Aug 22;9:30
pubmed: 25149184
Front Mol Neurosci. 2020 Mar 20;13:35
pubmed: 32265649
Mol Ther Nucleic Acids. 2018 Sep 7;12:146-157
pubmed: 30195754
Diabetes Res Clin Pract. 2017 Jun;128:40-50
pubmed: 28437734
Diabetes Obes Metab. 2010 May;12(5):384-92
pubmed: 20415686
Biochem Biophys Res Commun. 2015 Jul 17-24;463(1-2):60-3
pubmed: 25986735
Int J Biochem Cell Biol. 2013 Oct;45(10):2121-9
pubmed: 23665154
Nutr Metab Cardiovasc Dis. 2018 Feb;28(2):91-111
pubmed: 29170059
Exerc Immunol Rev. 2016;22:94-109
pubmed: 26859514
Clin Chem. 2017 Jan;63(1):186-195
pubmed: 28062618
BMC Bioinformatics. 2011 Mar 17;12:77
pubmed: 21414208
Indian J Clin Biochem. 2019 Jul;34(3):243-245
pubmed: 31391712
Gene. 2014 Jan 1;533(1):1-4
pubmed: 24120394
J Biol Chem. 2009 Jan 23;284(4):1971-81
pubmed: 18986979
Cardiovasc Diabetol. 2019 Aug 30;18(1):113
pubmed: 31470851
Clin Epigenetics. 2018 Apr 23;10:59
pubmed: 29713393
J Diabetes Res. 2016;2016:2798269
pubmed: 26649319
World J Diabetes. 2015 Mar 15;6(2):296-303
pubmed: 25789110
Front Nutr. 2019 Nov 27;6:179
pubmed: 31828076
Diabetes Res Clin Pract. 2011 Jan;91(1):94-100
pubmed: 21146880
Diabetes. 2019 Mar;68(3):556-570
pubmed: 30523026
Cell. 2004 Apr 30;117(3):399-412
pubmed: 15109499
J Diabetes Investig. 2015 Jan;6(1):44-50
pubmed: 25621132
Acta Diabetol. 2011 Mar;48(1):61-9
pubmed: 20857148
BMC Fam Pract. 2015 Jan 22;16:5
pubmed: 25609029
Cell Res. 2008 Oct;18(10):997-1006
pubmed: 18766170
J Diabetes Complications. 2017 May;31(5):918-927
pubmed: 28238556
Nat Rev Immunol. 2011 Feb;11(2):98-107
pubmed: 21233852
Acta Diabetol. 2020 Feb;57(2):203-214
pubmed: 31435783
Diabetes Care. 2007 Mar;30(3):753-9
pubmed: 17327355
Diabetes. 2015 May;64(5):1495-7
pubmed: 25908872
J Diabetes Investig. 2019 Jul;10(4):951-962
pubmed: 30592156
Antioxid Redox Signal. 2017 Nov 1;27(13):913-930
pubmed: 28173719
Mol Cell Probes. 2019 Dec;48:101445
pubmed: 31513891
Circ Res. 2010 Sep 17;107(6):810-7
pubmed: 20651284
Lancet. 2012 Jun 16;379(9833):2279-90
pubmed: 22683128
Metabolism. 2017 May;70:192-195
pubmed: 28095990
Neurosci Res. 2018 May;130:8-22
pubmed: 28803788
Mol Cell Biochem. 2011 May;351(1-2):197-205
pubmed: 21249428
J Diabetes Res. 2015;2015:943659
pubmed: 26273679
Clin Nutr. 2019 Oct;38(5):2231-2238
pubmed: 30309709
Diabetes Care. 2006 Jan;29 Suppl 1:S43-8
pubmed: 16373932
Cells. 2019 Nov 28;8(12):
pubmed: 31795194
Int J Mol Sci. 2018 Oct 24;19(11):
pubmed: 30355995
Biomed Pharmacother. 2019 Sep;117:109055
pubmed: 31176165
Prim Care Diabetes. 2019 Feb;13(1):3-10
pubmed: 30477970
Diabetes. 2014 Jul;63(7):2262-72
pubmed: 24931033
Diabetes Metab Syndr Obes. 2017 Aug 14;10:345-361
pubmed: 28860833
Front Neurosci. 2018 Jun 08;12:383
pubmed: 29950970
Front Med (Lausanne). 2015 Aug 03;2:51
pubmed: 26284247
Physiol Rep. 2018 Jul;6(14):e13810
pubmed: 30047243
Int J Mol Sci. 2016 Oct 17;17(10):
pubmed: 27763497
Int J Mol Sci. 2018 Nov 22;19(12):
pubmed: 30469501
F1000Res. 2019 Apr 3;8:
pubmed: 31001415
Nitric Oxide. 2009 Jun;20(4):223-30
pubmed: 19298861
Hormones (Athens). 2018 Sep;17(3):299-313
pubmed: 30171523
Int J Appl Basic Med Res. 2015 May-Aug;5(2):133-8
pubmed: 26097823
Clin Sci (Lond). 2019 Jan 3;133(1):23-40
pubmed: 30606812
Eur J Endocrinol. 2015 Mar;172(3):291-300
pubmed: 25515554
Physiol Rev. 2013 Jan;93(1):137-88
pubmed: 23303908